CSIMarket


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 

Candel Therapeutics Inc 's Tangible Leverage Ratio

CADL's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




CADL Tangible Leverage Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter



Y / Y Tangible Equity Change - - - - -
Y / Y Total Liabilities Change - - - - -
Tangible Leverage Ratio MRQ 0.09 - - - -
Overall Ranking # # # # #
Seq. Tangible Equity Change - - - - -
Seq. Total Liabilities Change -82.86 % - - - -



Tangible Leverage Ratio third quarter 2021 Comment
Despite repayements of liabilities of -82.86%, in III. Quarter ,Tangible Leverage Ratio detoriated to 0.09, a new company low.

Within Biotechnology & Pharmaceuticals industry in the third quarter 2021, 43 other companies have achieved lower Tangible Leverage Ratio than Candel Therapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is CADL Market Share?
Tangible Leverage Ratio third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 44
Healthcare Sector # 161
Overall Market # 306


Tangible Leverage Ratio Statistics
High Average Low
0.09 0.09 0.09
(Sep 30 2021)  




Financial Statements
Candel Therapeutics Inc 's Tangible Equity $ 63 Millions Visit CADL's Balance sheet
Candel Therapeutics Inc 's Total Liabilities $ 6 Millions Visit CADL's Balance sheet
Source of CADL's Sales Visit CADL's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingSep 30 2021, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioSep 30 2021 MRQ Total LiabilitiesSep 30 2021 MRQ Tangible Equity
Surface Oncology Inc   0.23 $ 29.989  Millions$ 131.197  Millions
Codex Dna Inc   0.22 $ 21.732  Millions$ 97.277  Millions
Aclaris Therapeutics Inc   0.22 $ 46.546  Millions$ 209.514  Millions
Surrozen Inc   0.22 $ 26.905  Millions$ 123.731  Millions
Pulmatrix Inc   0.21 $ 9.657  Millions$ 45.193  Millions
Aligos Therapeutics Inc   0.21 $ 46.057  Millions$ 217.011  Millions
Brickell Biotech Inc   0.21 $ 4.147  Millions$ 19.968  Millions
Alpha Teknova Inc   0.21 $ 22.937  Millions$ 110.622  Millions
Syndax Pharmaceuticals Inc   0.20 $ 40.499  Millions$ 199.004  Millions
Bioatla Inc   0.20 $ 46.926  Millions$ 230.653  Millions
Renovacare Inc   0.20 $ 0.670  Millions$ 3.326  Millions
Vaxart Inc   0.19 $ 36.188  Millions$ 190.886  Millions
Idera Pharmaceuticals Inc   0.19 $ 6.169  Millions$ 33.011  Millions
Allovir Inc   0.18 $ 49.226  Millions$ 267.304  Millions
Relay Therapeutics Inc   0.18 $ 100.527  Millions$ 568.788  Millions
Capricor Therapeutics inc   0.17 $ 6.365  Millions$ 36.736  Millions
Revolution Medicines Inc   0.17 $ 96.772  Millions$ 563.453  Millions
Talis Biomedical Corporation  0.17 $ 44.304  Millions$ 258.792  Millions
Lineage Cell Therapeutics Inc   0.17 $ 10.500  Millions$ 62.063  Millions
Igm Biosciences Inc   0.16 $ 46.653  Millions$ 285.576  Millions
Homology Medicines Inc  0.16 $ 32.245  Millions$ 198.571  Millions
Ayala Pharmaceuticals Inc   0.16 $ 6.360  Millions$ 39.384  Millions
Petvivo Holdings Inc  0.16 $ 1.366  Millions$ 8.505  Millions
89bio Inc   0.15 $ 21.286  Millions$ 146.770  Millions
Caribou Biosciences Inc   0.14 $ 57.559  Millions$ 404.401  Millions
Tscan Therapeutics Inc   0.14 $ 24.404  Millions$ 174.074  Millions
Mymd Pharmaceuticals Inc   0.14 $ 2.080  Millions$ 15.393  Millions
Fortium Holdings Corp   0.13 $ 0.091  Millions$ 0.677  Millions
Protagonist Therapeutics inc   0.13 $ 43.515  Millions$ 329.660  Millions
Vaxcyte Inc   0.13 $ 39.913  Millions$ 305.956  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PACV's Profile

Stock Price

PACV's Financials

Business Description

Fundamentals

Charts & Quotes

PACV's News

Suppliers

PACV's Competitors

Customers & Markets

Economic Indicators

PACV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071